230 related articles for article (PubMed ID: 32818756)
1. A single- center experience of prolactin-producing pituitary adenomas without hyperprolactinemia: Its incidence and clinical management.
Ogawa Y; Tominaga T
Clin Neurol Neurosurg; 2020 Nov; 198():106123. PubMed ID: 32818756
[TBL] [Abstract][Full Text] [Related]
2. Mid-term prognosis of non-functioning pituitary adenomas with high proliferative potential: really an aggressive variant?
Ogawa Y; Jokura H; Niizuma K; Tominaga T
J Neurooncol; 2018 May; 137(3):543-549. PubMed ID: 29318507
[TBL] [Abstract][Full Text] [Related]
3. Hyperprolactinemia and prolactinoma.
Romijn JA
Handb Clin Neurol; 2014; 124():185-95. PubMed ID: 25248588
[TBL] [Abstract][Full Text] [Related]
4. Macroprolactinomas and Nonfunctioning Pituitary Adenomas and Pregnancy Outcomes.
Lambert K; Rees K; Seed PT; Dhanjal MK; Knight M; McCance DR; Williamson C
Obstet Gynecol; 2017 Jan; 129(1):185-194. PubMed ID: 27926659
[TBL] [Abstract][Full Text] [Related]
5. Gamma knife radiosurgery for pituitary adenoma: early results.
Petrovich Z; Yu C; Giannotta SL; Zee CS; Apuzzo ML
Neurosurgery; 2003 Jul; 53(1):51-9; discussion 59-61. PubMed ID: 12823873
[TBL] [Abstract][Full Text] [Related]
6. Gamma Knife radiosurgery for the management of nonfunctioning pituitary adenomas: a multicenter study.
Sheehan JP; Starke RM; Mathieu D; Young B; Sneed PK; Chiang VL; Lee JY; Kano H; Park KJ; Niranjan A; Kondziolka D; Barnett GH; Rush S; Golfinos JG; Lunsford LD
J Neurosurg; 2013 Aug; 119(2):446-56. PubMed ID: 23621595
[TBL] [Abstract][Full Text] [Related]
7. Long-term results of stereotactic gamma knife radiosurgery for pituitary adenomas. Specific strategies for different types of adenoma.
Kobayashi T
Prog Neurol Surg; 2009; 22():77-95. PubMed ID: 18948721
[TBL] [Abstract][Full Text] [Related]
8. Results of stereotactic radiosurgery in patients with hormone-producing pituitary adenomas: factors associated with endocrine normalization.
Pollock BE; Nippoldt TB; Stafford SL; Foote RL; Abboud CF
J Neurosurg; 2002 Sep; 97(3):525-30. PubMed ID: 12296634
[TBL] [Abstract][Full Text] [Related]
9. Hormone levels and tumour size response to quinagolide and cabergoline in patients with prolactin-secreting and clinically non-functioning pituitary adenomas: predictive value of pituitary scintigraphy with 123I-methoxybenzamide.
Colao A; Ferone D; Lastoria S; Cerbone G; Di Sarno A; Di Somma C; Lucci R; Lombardi G
Clin Endocrinol (Oxf); 2000 Apr; 52(4):437-45. PubMed ID: 10762286
[TBL] [Abstract][Full Text] [Related]
10. True hyperprolactinemia in men without visible pituitary adenoma.
Shimon I; Rudman Y; Manisterski Y; Gorshtein A; Masri H; Duskin-Bitan H
Endocrine; 2021 Jun; 72(3):809-813. PubMed ID: 33566310
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients.
Gsponer J; De Tribolet N; Déruaz JP; Janzer R; Uské A; Mirimanoff RO; Reymond MJ; Rey F; Temler E; Gaillard RC; Gomez F
Medicine (Baltimore); 1999 Jul; 78(4):236-69. PubMed ID: 10424206
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Outcome of Nonfunctioning and Hormonal Active Pituitary Adenoma After Gamma Knife Radiosurgery.
Narayan V; Mohammed N; Bir SC; Savardekar AR; Patra DP; Bollam P; Nanda A
World Neurosurg; 2018 Jun; 114():e824-e832. PubMed ID: 29574220
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of pituitary adenomas].
Mezosi E; Nemes O
Orv Hetil; 2009 Sep; 150(39):1803-10. PubMed ID: 19758960
[TBL] [Abstract][Full Text] [Related]
14. Four years' experiences in the treatment of pituitary adenomas with gamma knife radiosurgery.
Lim YL; Leem W; Kim TS; Rhee BA; Kim GK
Stereotact Funct Neurosurg; 1998 Oct; 70 Suppl 1():95-109. PubMed ID: 9782241
[TBL] [Abstract][Full Text] [Related]
15. Treatment of pituitary adenomas using radiosurgery and radiotherapy: a single center experience and review of literature.
Sun DQ; Cheng JJ; Frazier JL; Batra S; Wand G; Kleinberg LR; Rigamonti D; Quinones-Hinojosa A; Salvatori R; Lim M
Neurosurg Rev; 2010 Apr; 34(2):181-9. PubMed ID: 20838838
[TBL] [Abstract][Full Text] [Related]
16. Contemporary management of prolactinomas.
Liu JK; Couldwell WT
Neurosurg Focus; 2004 Apr; 16(4):E2. PubMed ID: 15191331
[TBL] [Abstract][Full Text] [Related]
17. Osteoporotic fractures in patients with untreated hyperprolactinemia vs. those taking dopamine agonists: A systematic review and meta-analysis.
D'Sylva C; Khan T; Van Uum S; Fraser LA
Neuro Endocrinol Lett; 2015; 36(8):745-9. PubMed ID: 26921574
[TBL] [Abstract][Full Text] [Related]
18. Pituitary adenomas treated with gamma knife radiosurgery: volumetric analysis of 100 cases with minimum 3 year follow-up.
Pamir MN; Kiliç T; Belirgen M; Abacioğlu U; Karabekiroğlu N
Neurosurgery; 2007 Aug; 61(2):270-80; discussion 280. PubMed ID: 17762739
[TBL] [Abstract][Full Text] [Related]
19. Hyperprolactinemia: pathophysiology and management.
Verhelst J; Abs R
Treat Endocrinol; 2003; 2(1):23-32. PubMed ID: 15871552
[TBL] [Abstract][Full Text] [Related]
20. Gamma knife radiosurgery: a safe and effective salvage treatment for pituitary tumours not controlled despite conventional radiotherapy.
Swords FM; Monson JP; Besser GM; Chew SL; Drake WM; Grossman AB; Plowman PN
Eur J Endocrinol; 2009 Dec; 161(6):819-28. PubMed ID: 19773368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
